About MORGAN AND MENDEL GENOMICS, INC
Morgan Mendel Genomics is a company focused on leading the next generation of genomic risk assessment testing using novel flow cytometry-based technologies to deliver faster, more accurate, and less expensive genetic tests for cancer risk assessment and therapy candidacy.
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| NOVEL, RAPID AND ACCURATE BLOOD TESTS FOR DETECTING HEREDITARY CANCER RISK | Department of Defense | $695K | |
| Federal contract award | Department of Defense | $50K |
Is this your company?
Claim MORGAN AND MENDEL GENOMICS, INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim MORGAN AND MENDEL GENOMICS, INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.